SEOUL, Aug. 10 (Korea Bizwire) — Concerns exist that individuals with mental disorders who choose to discontinue their treatment could experience worsened symptoms due to lack of attention and isolation from medical institutions, government, and local communities, resulting in a lack of social support. The individuals under the purview of the health authority’s case management [...]
SEOUL, Oct. 19 (Korea Bizwire) — Individuals being treated for pedophilia account for an extremely small portion of perpetrators of child sexual abuse, pointing out the need for wider coverage of mental health treatment, data showed Tuesday. Rep. Shin Hyun-young of the Democratic Party referred to a Health Insurance Review & Assessment Service report which [...]
SEOUL, May 19 (Korea Bizwire) — Seoul’s Seondong district office said Wednesday it is introducing the country’s first policy of providing the younger generation with subsidies for hair loss treatment. The district enacted relevant ordinances earlier this month to set up a legal basis for the initiative. The ordinance defines ‘hair loss’ as a disease [...]
SEOUL, Feb. 25 (Korea Bizwire) — Video games specially developed to treat attention deficit hyperactivity disorder (ADHD) are capable of increasing the blood flow that is lacking in certain parts of the brain, a study showed Thursday. A research team from Chung-Ang University Hospital created a game co-developed by public agencies and private companies and [...]
SEOUL, Oct. 15 (Korea Bizwire) — Amid a recent increase in the number of drug-dependent people, the government is taking steps step to strengthen drug addiction treatment and protection systems by extending the range of financial support from hospital treatment to outpatient treatment. The Ministry of Health and Welfare said Thursday that it had issued [...]
San Diego, USA, Oct. 6 (Korea Bizwire) – Covicept Therapeutics, an antiviral drug development company, announced today that a double-blind, placebo-controlled Phase 2 trial of PSJ-539 has been initiated and has begun enrolling patients with mild-to-moderate COVID-19. PSJ-539 has the potential to become a best-in-class small molecule for the treatment of COVID-19 patients and also has potential [...]
SEOUL, Feb. 20 (Korea Bizwire) — South Korean biopharmaceutical company Celltrion Inc. will supply its antibody treatment for COVID-19 without a profit margin in South Korea, its chairman has said. Celltrion’s CT-P59 won the South Korean drug safety agency’s conditional approval earlier this month, becoming the first locally made treatment for the virus. The drug [...]
SEOUL, Nov. 24 (Korea Bizwire) – South Korea’s drug safety agency has approved clinical trials of vaccine and treatment candidates currently under development by two local drug manufacturers, industry officials said Tuesday. The Ministry of Food and Drug Safety on Monday gave the green light to conduct a phase one clinical trial of a vaccine [...]
SEOUL, Sept. 8 (Korea Bizwire) – South Korea plans to mass-produce an antibody material later this month that can be used to treat the novel coronavirus, health authorities said Tuesday. The country’s Ministry of Food and Drug Safety is currently reviewing phase 2/3 clinical tests for the antibody-based treatment, and aims to mass-produce so-called production verification [...]
SEOUL, Aug. 5 (Korea Bizwire) — Nafamostat, a drug used to treat acute pancreatitis and prevent blood clotting for patients receiving blood dialysis, was found to be effective against COVID-19, the disease caused by the novel coronavirus. Professors Rhee Ji-young and Jang Suk-bin from Dankook University Hospital published an article detailing the use of nafamostat [...]